Torl Biotherapeutics, Llc
Clinical trials sponsored by Torl Biotherapeutics, Llc, explained in plain language.
-
New drug TORL-3-600 tested in patients with advanced cancer
Disease control OngoingThis early-stage study tests a new drug called TORL-3-600 in 70 adults with advanced solid tumors or colorectal cancer. The main goals are to find a safe dose and check for side effects. Researchers will also see if the drug can shrink tumors or slow cancer growth.
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
New drug trial hopes to shrink Hard-to-Treat tumors
Disease control OngoingThis early-stage study tests a new drug called TORL-2-307-ADC in 163 people with advanced solid tumors, including stomach, pancreas, and esophageal cancers. The main goals are to find a safe dose and check for side effects. Researchers will also see if the drug can shrink tumors …
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated May 05, 2026 11:56 UTC